Johnson & Johnson, a leading global healthcare company, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1886, the company has established itself as a pioneer in the pharmaceutical, medical devices, and consumer health sectors. With a diverse portfolio that includes renowned products such as Band-Aid, Tylenol, and Neutrogena, Johnson & Johnson is distinguished by its commitment to innovation and quality. The company has achieved significant milestones, including the development of groundbreaking medical technologies and vaccines. As a trusted name in healthcare, Johnson & Johnson holds a strong market position, consistently ranking among the top companies in the industry. Its dedication to improving global health outcomes underscores its reputation as a leader in the healthcare landscape.
How does Johnson And Johnson's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Johnson And Johnson's score of 76 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Johnson & Johnson reported total greenhouse gas emissions of approximately 442,880,000 kg CO2e, encompassing Scope 1, Scope 2, and Scope 3 emissions. The company has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 emissions by 60% by 2030 from a 2016 baseline. Additionally, Johnson & Johnson targets a 20% reduction in absolute upstream Scope 3 emissions over the same period. These targets include biogenic emissions and removals from bioenergy feedstocks. In 2021, the company reported Scope 1 emissions of about 329,756,000 kg CO2e and Scope 2 emissions of approximately 244,409,000 kg CO2e. The commitment to reduce emissions aligns with the Science Based Targets initiative (SBTi) and reflects Johnson & Johnson's dedication to sustainability within the pharmaceutical and biotechnology sector. The company is also focused on ensuring that 80% of its suppliers by emissions will have science-based targets by 2028, further enhancing its climate strategy.
Access structured emissions data, company-specific emission factors, and source documents
1990 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 308,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 751,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Johnson And Johnson is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.